ERIC ZYWICKI: Open Payments
NPI 1851801443 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,244 in 100 payments from 13 companies in 2025. Trend: 2023 $1,294 · 2024 $951 · 2025 $2,244
Food & beverage: $2,244
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $310 |
| E.R. Squibb & Sons, L.L.C. | 10 | $308 |
| Axsome Therapeutics, Inc. | 10 | $281 |
| Janssen Pharmaceuticals, Inc | 11 | $273 |
| Otsuka America Pharmaceutical, Inc. | 13 | $265 |
| Alkermes, Inc. | 14 | $240 |
| Tris Pharma Inc | 9 | $178 |
| Lundbeck LLC | 11 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
Products named: COBENFY, Auvelity, REXULTI, FANAPT, ARISTADA, INVEGA SUSTENNA, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
